The prognostic value of thrombocytosis associated with non small cell lung carcinoma.

被引：0
|
作者：
Quispe, D [1 ]
Hanbali, A [1 ]
Wollner, I [1 ]
机构：
[1] Henry Ford Hosp, Dept Hematol Oncol, Detroit, MI 48202 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.3992.3992
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3992
引用
收藏
页码：77B / 78B
页数：2
相关论文
共 50 条
  • [1] Prognostic value of LIPC in non-small cell lung carcinoma
    Galluzzi, Lorenzo
    Goubar, Aicha
    Olaussen, Ken Andre
    Vitale, Ilio
    Senovilla, Laura
    Michels, Judith
    Robin, Angelique
    Dorvault, Nicolas
    Besse, Benjamin
    Validire, Pierre
    Fouret, Pierre
    Behrens, Carmen
    Wistuba, Ignacio Ivan
    Soria, Jean-Charles
    Kroemer, Guido
    CELL CYCLE, 2013, 12 (04) : 647 - 654
  • [2] Prognostic value of thrombocytosis in renal cell carcinoma
    Bensalah, K
    Leray, E
    Fergelot, P
    Rioux-Leclercq, N
    Tostain, J
    Guillé, F
    Patard, JJ
    JOURNAL OF UROLOGY, 2006, 175 (03): : 859 - 863
  • [3] Prognostic significance of leucocytosis in patients with metastatic non-small cell lung carcinoma.
    Ameadour, Lamiae
    Benbrahim, Zineb
    Ziani, Fatima Zahra
    Boudahna, Lamlae
    Sy, Osmane
    Arifi, Samia
    Mellas, Nawfel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Prognostic value of DNA cytometry in patients with non-small cell lung carcinoma
    Skuballa, A
    Starke, U
    Achatzy, R
    Hutschenreiter, J
    6TH EUROPEAN CONFERENCE ON GENERAL THORACIC SURGERY, 1998, : 89 - 92
  • [5] Paraneoplastic Leukocytosis and Thrombocytosis as Prognostic Biomarkers in Non-small Cell Lung Cancer
    Prajwal BODDU
    Dana VILLLINES
    Mebea AKLILU
    中国肺癌杂志, 2016, (11) : 725 - 730
  • [6] Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma.
    Hasselle, M. D.
    Rusthoven, K. E.
    Macrie, B. D.
    Shah, N.
    Golden, D. W.
    Weichselbaum, R. R.
    Salama, J. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] PROGNOSTIC VALUE OF PLOIDY AND PROLIFERATIVE ACTIVITY IN NON-SMALL CELL LUNG-CARCINOMA
    VOLM, M
    MATTERN, J
    SONKA, J
    WAYSS, K
    DRINGS, P
    VOGTMOYKOPF, I
    TUMORDIAGNOSTIK & THERAPIE, 1985, 6 (01) : 8 - 13
  • [8] Prognostic value and therapeutic consequences of vascular invasion in non-small cell lung carcinoma
    Bodendorf, Marc Oliver
    Haas, Victor
    Laberke, Hans-Gerd
    Blumenstock, Gunnar
    Wex, Peter
    Graeter, Thomas
    LUNG CANCER, 2009, 64 (01) : 71 - 78
  • [9] Prognostic factors in non-small cell lung carcinoma
    Koutsami, MK
    Gorgoulis, VG
    Kastrinakis, NG
    Asimacopoulos, PJ
    Kittas, C
    ANTICANCER RESEARCH, 2002, 22 (1A) : 347 - 374
  • [10] The role of new agents in advanced non-small-cell lung carcinoma.
    Langer C.J.
    Current Oncology Reports, 2000, 2 (1) : 76 - 89
12345